In this video, watch a panel of multidisciplinary physicians discuss the reasons why patients afflicted with acute hepatic porphyria (AHP) are often misdiagnosed or remain undiagnosed for up to 15 years. Learn about when they would consider suspecting, testing for and diagnosing AHP.
Faculty
Moderator: Amy Simon, MD
Vice President, Clinical Research
Alnylam Pharmaceuticals, Inc.
Cambridge, Massachusetts
Srikanth Nagalla, MD
Hematologist
UT Southwestern Medical Center
Dallas, Texas
Bruce Wang, MD
Hepatologist
University of California – San Francisco (UCSF)
San Francisco, California
Sponsored by Alnylam Pharmaceuticals, Inc.